Underweight SPCX: Trim 25-30% front-loaded at $143-145 with $140 stop, implementing 9/14 SPCX, AMD 9/11, and 9/11 SPCX binding lessons on overlay density and high-beta collar failure.
Override Research Manager's Hold and Trader's Hold with Underweight, trim 25-30% of SPCX front-loaded at $143-145 in single execution window (not waiting for $150+ resistance), residual stop at $140 (just below 200 SMA at $142.32). The decision implements three binding lessons: (1) 9/14 SPCX reflection—8+ bearish overlays mandate anchoring magnitude to midpoint/upper bound of shifted trim range; (2) AMD 9/11 cross-ticker—when clean collar cannot be put on high-beta, catalyst-sensitive name, default to Underweight or full trim; (3) 9/11 SPCX reflection—bearish catalyst count exceeds 4 independent overlays shifts trim default upward by at least one tier. Ten stacking overlays today: 82x forward P/E, bearish MACD cross, session-low close, 200 SMA at risk (1.17 points below), Starship Flight 14 within two weeks (91% Polymarket explosion probability), 5%+ 10-year yield with 94% odds of zero Fed cuts in 2026, $47B lockup overhang still ahead, Q3 earnings binary, merger timing optionality beyond horizon, Anthropic/IPO supply pressure. The $94B cash fortress and institutional floor (Nvidia $21B, Harvard $2.2B, Alphabet $94B) bound absolute downside—preventing full Sell—while Q2 audited operational inflection (+92% YoY revenue, +1,140bps gross margin expansion, $4.1B EBITDA swing) confirms the structural recovery story. Re-engagement triggers: Starship nominal outcome + daily close above $153.36 on volume >90M with MACD histogram expanding + Q3 2026 print with GM >50% and revenue growth >70% YoY. Full Sell on daily close below $130 on volume >70M, or Q3 2026 print with GM <45% or revenue deceleration <50% YoY, or FAA stand-down extending beyond 60 days following Flight 14 anomaly.
| Position | Action |
|---|---|
| Current position | Trim 25-30% of SPCX exposure |
| Starship Flight 14 within 2 weeks with 10 stacking bearish overlays | Execute trim front-loaded at $143-145 in single execution window; do not stage or wait for $150+ |
| Daily close below $140 on volume >60M | Stop triggered; accelerate trim on residual by 50% |
| Re-engagement conditions met (Starship nominal outcome + daily close above $153 on volume >90M with MACD histogram expanding + Q3 2026 GM >50% and revenue growth >70% YoY) | Scale position to benchmark weight |
| Two of three re-engagement conditions met | Scale to 80% of benchmark weight |
The bear is misreading short-term technical noise on a company whose Q2 2026 fundamentals — 91.9% revenue growth, gross margins at 55.3%, and $4.1 billion in sequential EBITDA improvement — have structurally repriced the equity, supported by a $94.35 billion cash fortress and the deepest catalyst pipeline in the space industry.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 146.43 | bearish |
| close_50_sma | 134.46 | bullish |
| close_200_sma | 142.32 | neutral |
| rsi | 51.25 | neutral |
| macd | 3.66 | bearish |
| macd_signal | 3.69 | bearish |
| macd_histogram | -0.03 | bearish |
| bollinger_middle | 143.26 | neutral |
| bollinger_upper | 154.15 | neutral |
| bollinger_lower | 132.38 | neutral |
| vwma | 146.19 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Upgrade to Hold/Overweight and scale to benchmark weight
Q2 2026 earnings represent a structural inflection that obsoletes trailing loss-making narrative
↩ rebuts: “Bear's claim that SPCX is a 'loss-making' company quoting trailing numbers”
· concedes: Valuation is rich at forward P/E of 82x; Capex is enormous at $19B/quarter; Quarterly volatility is brutal; Lockup expirations and IPO supply are real risks
SPCX is priced for perfection at 82x forward P/E with $19B/quarter capex burning, volatile 15-91% revenue growth, and a Starship program with 91% explosion risk on Flight 14—requiring every catalyst to clear cleanly while the bear only needs one to fail.
· concedes: Q2 numbers are impressive: +91.9% YoY revenue growth, 55.3% gross margin, EBITDA swinging positive by $4.1B sequentially; Valuation is rich; Capex is enormous; Quarterly volatility is brutal; Lockup expirations and IPO supply are real risks; Medium-term uptrend from $108 is technically intact until it breaks; Amazon 6-rocket order does show SpaceX is the dominant player; LEO broadband lead is real; Defense demand is growing; Nvidia orbital compute inclusion will drive passive flows
→ vs conservative: Trim of 25-30% into Flight 14 sells priced-in explosion risk to avoid tail that has been capitalized; true asymmetry is on upside if nominal flight occurs
→ vs conservative: 82x forward P/E at 5% 10-year yield is not structurally hostile given Q2 2026 inflected fundamentals; same macro backdrop produced +91.9% revenue growth and $4.1B EBITDA swing
→ vs conservative: $130-$134 add zone requires structural breakdown of August recovery; plan asks to add only after thesis is wounded, which is backward for asymmetric positioning
→ vs conservative: Stop at 142.32 (200 SMA) anchors to noise level; daily close below 142.32 does not invalidate multi-quarter operating leverage thesis
→ vs conservative: Bear case aphorism that 'bull needs every catalyst while bear needs one disappointment' contradicts price action showing three months of absorbed disappointments with stock holding August lows
→ vs neutral: Consolidation probability of 15% and 45/40 bull/bear split misses positive convexity framework; upside scenarios meaningfully outnumber downside given three independent uncorrelated catalysts converging
→ vs neutral: Valuation caution confuses richly priced stock with fragile stock; $94B cash position and completed capital raise make current valuation robust, not fragile
→ vs conservative: If flush to $130 on real damage, thesis requires re-evaluation from scratch rather than being a systematic add zone
| bearish |
| atr | 7.45 | neutral |
| volume | 71.5M shares | neutral |
Support: 142.32 · 134.46 · 132.38 · 108.27 | Resistance: 146.43 · 149.74 · 153.47 · 154.15
SPCX exhibits a mixed technical setup with medium-term bullish structure intact (above 50 SMA by 6.7%) but near-term weakness (below 10 EMA and VWMA, fresh MACD bearish cross). The 200 SMA at 142.32 represents a critical "line in the sand" test for the August recovery's validity. Bollinger compression at the mid-band suggests an imminent directional decision, with support at 142.32/134.46 and resistance at 146.43/153.47. Recommended action is HOLD with stops anchored near 128.59 (2× ATR), awaiting clean resolution at key levels before initiating new directional positions.
Market Cap
$1.8915T
52-Week High
$225.64
52-Week Low
$104.83
50-Day Average
$134.80
200-Day Average
$142.31
Forward P/E
82.32x
Price-to-Book
14.86x
EPS (TTM)
($1.10)
Forward EPS
$1.74
Book Value/Share
$9.66
Revenue Q2 2026
$7,814M
Revenue YoY Growth Q2 2026
+91.9%
Revenue Q1 2026
$4,694M
Revenue YoY Growth Q1 2026
+15.4%
TTM Revenue
$23.04B
Gross Margin Q2 2026
55.3%
Operating Margin Q2 2026
-1.8%
EBITDA Q2 2026
$2.96B
EBITDA Q1 2026
($1.16B)
Net Income Q2 2026
($541M)
Net Income Q1 2026
($4.28B)
TTM Net Income
($8.89B)
Profit Margin TTM
-35.7%
Cash Q2 2026
$93,522M
Total Cash & ST Investments Q2 2026
$100,009M
Total Assets Q2 2026
$192,770M
Stockholders' Equity Q2 2026
$127,224M
Total Debt Q2 2026
$39,708M
Working Capital Q2 2026
$86,925M
Debt-to-Equity
31.2%
Current Ratio
5.12
PP&E Net Q2 2026
$66.85B
Construction In Progress Q2 2026
$12.55B
Goodwill
$11.65B
Retained Earnings
($41.85B)
Additional Paid-In Capital Q2 2026
$167.34B
OCF Q2 2026
$2,419M
OCF Q1 2026
$1,047M
OCF Q2 2025
($376M)
CapEx Q2 2026
($19,238M)
CapEx Q1 2026
($10,114M)
CapEx Q2 2025
($2,847M)
FCF Q2 2026
($16,819M)
FCF Q1 2026
($9,067M)
FCF Q2 2025
($3,223M)
Equity Raised Q2 2026
$85.7B
Preferred Stock Retired
$7.05B
Shares Outstanding
13.18B
Diluted EPS Q2 2026
($0.09)
Interest Expense Q2 2026
$629M
R&D Spending Q2 2026
$3.55B
R&D Spending YoY Growth
+81%
SG&A Q2 2026
$912M
SG&A YoY Growth
+50%
Depreciation Q2 2026
$2.85B
Strengths
Concerns
SPCX demonstrates a high-conviction long-term growth thesis with the recent $85.7B capital raise providing years of operational runway, but the valuation premium of 82x forward P/E demands flawless execution. Revenue inflecting 91.9% YoY with 55% gross margins validates the operating leverage thesis, and the fortress balance sheet ($94B cash vs $40B debt) de-risks the equity story substantially. However, persistent GAAP losses, deeply negative FCF from heavy CapEx investment, and premium valuation make this suitable only for investors with 3-5 year time horizons and high risk tolerance. Key catalysts to monitor include Starship commercial flight cadence, Starlink subscriber growth and ARPU, defense contract wins, and quarterly FCF trajectory improvement toward profitability targets.
Macro: The dominant macro theme is a violent repricing of the long end of the U.S. Treasury curve, with the 10Y briefly surpassing 5.00% for the first time since 2023. This is occurring alongside sticky inflation, WTI oil above $100/bbl (55% implied probability of hitting $110 in September), and 94% odds of zero Fed rate cuts in 2026. Polymarket shows 0% probability of any cuts across all path scenarios (6 through 12 cuts). Recession odds have ticked up to 15% (+7.5pp w/w), though still below historical stress thresholds. Treasury Secretary Bessent unveiled $6B in bond buybacks and signaled activist posture on yen intervention. Long-duration equities, especially freshly-IPO'd unprofitable growth names like SPCX, face the most severe rate sensitivity.